Disseminated Salmonella paratyphi infection in a rheumatoid arthritis patient treated with infliximab

M. Bassetti, E. Nicco, E. Delfino, C. Viscoli

Research output: Contribution to journalArticlepeer-review

Abstract

Anti-tumour necrosis factor (TNF)-α treatments are immunosuppressant and represent an important risk factor for developing infections. We report a case of Salmonella paratyphi bacteraemia associated with soft tissue infection in a patient who used infliximab and had recently travelled to India. This case report provides supporting evidence, essentially based only on case reports, that patients receiving anti-TNF-α treatments have an increased susceptibility to Salmonella infections, which may develop at unusual and disseminated sites. We emphasize the importance of appropriate counselling of patients undergoing anti-TNF treatment and travelling to areas in which Salmonellae are endemic, as well as the importance of advice to these patients concerning food hygiene.

Original languageEnglish
Pages (from-to)84-85
Number of pages2
JournalClinical Microbiology and Infection
Volume16
Issue number1
DOIs
Publication statusPublished - Jan 2010

Keywords

  • Bacteraemia
  • Disseminated infection
  • Infliximab
  • Rheumatoid arthritis
  • Salmonella paratyphi

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Disseminated Salmonella paratyphi infection in a rheumatoid arthritis patient treated with infliximab'. Together they form a unique fingerprint.

Cite this